Literature DB >> 2607176

Purification and characterization of a human Mx protein.

G Weitz1, J Bekisz, K Zoon, H Arnheiter.   

Abstract

Human interferon-beta (IFN-beta) induces in human embryonic foreskin fibroblasts a cytoplasmic protein with antigenic similarities to mouse Mx protein, a nuclear protein implicated in inhibition of influenza virus replication. The human protein was purified to virtual homogeneity by immunoaffinity chromatography using a monoclonal antibody to mouse Mx protein. The purified protein has an apparent Mr of 78,000 and displays a strong tendency to self-aggregate. It can be resolved on two-dimensional gels into four spots with pIs between 6.0 and 6.2, each of which reacts with antibodies to mouse Mx protein. The partial amino-terminal sequence was determined for the affinity-purified protein. Cytoplasmic microinjection of the affinity-purified protein does not lead to efficient protection against infection with influenza virus. Cytoplasmic microinjection of the monoclonal Mx antibody, which increases suceptibility of IFN-treated mouse Mx cells to influenza virus, does not alter the viral susceptibility of IFN-treated human cells. These results suggest that, unlike the mouse Mx protein, the human Mx protein studied in this communication may not be sufficient to confer to cells a high degree of protection against influenza virus.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2607176     DOI: 10.1089/jir.1989.9.679

Source DB:  PubMed          Journal:  J Interferon Res        ISSN: 0197-8357


  4 in total

Review 1.  Risks and benefits of interferon-alpha in the treatment of hepatitis.

Authors:  M Pardo; E Marriott; M C Moliner; J A Quiroga; V Carreño
Journal:  Drug Saf       Date:  1995-11       Impact factor: 5.606

2.  Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein.

Authors:  J Pavlovic; T Zürcher; O Haller; P Staeheli
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

3.  Molecular and functional analysis of the virus- and interferon-inducible human MxA promoter.

Authors:  K C Chang; E Hansen; L Foroni; J Lida; G Goldspink
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

Review 4.  The use of interferon-alpha in virus infections.

Authors:  N B Finter; S Chapman; P Dowd; J M Johnston; V Manna; N Sarantis; N Sheron; G Scott; S Phua; P B Tatum
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.